foxo4 dri senolytic peptide human trial FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice 2026 FDA Peptide Reclassification Size:Gallon Pica
Pay in 4 interest-free payments of $6.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10